Cibus (CBUS) Competitors $2.64 -0.16 (-5.71%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends CBUS vs. ASPI, LXFR, ARQ, SLI, SDST, ORGN, AMTX, VGAS, ALTO, and TLGYShould you be buying Cibus stock or one of its competitors? The main competitors of Cibus include ASP Isotopes (ASPI), Luxfer (LXFR), ARQ (ARQ), Standard Lithium (SLI), Stardust Power (SDST), Origin Materials (ORGN), Aemetis (AMTX), Verde Clean Fuels (VGAS), Alto Ingredients (ALTO), and TLGY Acquisition (TLGY). These companies are all part of the "chemicals" industry. Cibus vs. ASP Isotopes Luxfer ARQ Standard Lithium Stardust Power Origin Materials Aemetis Verde Clean Fuels Alto Ingredients TLGY Acquisition Cibus (NASDAQ:CBUS) and ASP Isotopes (NASDAQ:ASPI) are both small-cap consumer staples companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, media sentiment, profitability, institutional ownership, community ranking and valuation. Do analysts recommend CBUS or ASPI? Cibus currently has a consensus price target of $22.83, indicating a potential upside of 764.90%. ASP Isotopes has a consensus price target of $4.50, indicating a potential downside of 7.98%. Given Cibus' stronger consensus rating and higher possible upside, research analysts plainly believe Cibus is more favorable than ASP Isotopes.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cibus 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.25ASP Isotopes 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is CBUS or ASPI more profitable? ASP Isotopes has a net margin of -807.39% compared to Cibus' net margin of -10,724.78%. Cibus' return on equity of -28.17% beat ASP Isotopes' return on equity.Company Net Margins Return on Equity Return on Assets Cibus-10,724.78% -28.17% -13.39% ASP Isotopes -807.39%-123.83%-51.58% Which has more volatility and risk, CBUS or ASPI? Cibus has a beta of 1.86, suggesting that its stock price is 86% more volatile than the S&P 500. Comparatively, ASP Isotopes has a beta of 3.27, suggesting that its stock price is 227% more volatile than the S&P 500. Does the MarketBeat Community believe in CBUS or ASPI? Cibus received 4 more outperform votes than ASP Isotopes when rated by MarketBeat users. CompanyUnderperformOutperformCibusOutperform Votes11100.00% Underperform VotesNo VotesASP IsotopesOutperform Votes7100.00% Underperform VotesNo Votes Do insiders and institutionals hold more shares of CBUS or ASPI? 33.8% of Cibus shares are owned by institutional investors. Comparatively, 16.8% of ASP Isotopes shares are owned by institutional investors. 49.4% of Cibus shares are owned by insiders. Comparatively, 21.4% of ASP Isotopes shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has stronger earnings & valuation, CBUS or ASPI? ASP Isotopes has lower revenue, but higher earnings than Cibus. ASP Isotopes is trading at a lower price-to-earnings ratio than Cibus, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCibus$4.15M16.82-$267.64M-$22.48-0.12ASP Isotopes$3.38M103.18-$16.29M-$0.61-8.02 Does the media refer more to CBUS or ASPI? In the previous week, ASP Isotopes had 26 more articles in the media than Cibus. MarketBeat recorded 32 mentions for ASP Isotopes and 6 mentions for Cibus. ASP Isotopes' average media sentiment score of 0.12 beat Cibus' score of -0.15 indicating that ASP Isotopes is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cibus 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral ASP Isotopes 5 Very Positive mention(s) 2 Positive mention(s) 24 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryCibus beats ASP Isotopes on 10 of the 17 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get Cibus News Delivered to You Automatically Sign up to receive the latest news and ratings for CBUS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CBUS vs. The Competition Export to ExcelMetricCibusAgricultural chemicals IndustryStaples SectorNASDAQ ExchangeMarket Cap$74.08M$4.40B$14.03B$9.07BDividend YieldN/A3.54%2.77%4.22%P/E Ratio-0.1240.5021.9617.19Price / Sales16.823.402.60116.80Price / Cash0.537.5521.1437.86Price / Book0.210.845.854.78Net Income-$267.64M$340.44M$572.90M$225.60M7 Day Performance-35.29%-11.61%-1.84%-1.24%1 Month Performance-39.59%-8.15%-3.05%3.36%1 Year Performance-84.63%-38.78%2.93%16.58% Cibus Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CBUSCibus1.6199 of 5 stars$2.64-5.7%$22.83+764.9%-82.8%$74.08M$4.15M-0.12183High Trading VolumeASPIASP Isotopes0.6583 of 5 stars$5.78+15.6%$4.50-22.1%+181.0%$412.63M$3.38M-9.3176High Trading VolumeLXFRLuxfer3.4121 of 5 stars$13.90+2.0%N/A+44.8%$372.31M$384.40M41.301,400Analyst DowngradeNews CoverageARQARQ3.5614 of 5 stars$7.11+0.3%$10.00+40.6%N/A$298.85M$110.02M-709.00140SLIStandard Lithium1.4669 of 5 stars$1.48-0.3%$3.95+167.8%N/A$254.81MN/A2.51N/ANews CoverageSDSTStardust Power2.5706 of 5 stars$5.30-0.6%$12.50+135.8%N/A$254.06MN/A0.00N/AAnalyst ForecastNews CoverageORGNOrigin Materials3.3242 of 5 stars$1.13-1.7%$3.00+165.3%+14.1%$165.41M$35.12M-1.92160AMTXAemetis1.4991 of 5 stars$3.00-0.3%$12.95+331.7%-47.9%$149.22M$186.72M-1.33160VGASVerde Clean Fuels0.1668 of 5 stars$3.64+1.4%N/A+69.8%$116.66MN/A-7.182News CoveragePositive NewsGap DownALTOAlto Ingredients3.3545 of 5 stars$1.47+0.5%$5.50+274.7%-48.1%$112.52M$1.00B-2.81420Positive NewsTLGYTLGY AcquisitionN/A$11.64flatN/A+5.1%$110.23MN/A0.003Positive News Related Companies and Tools Related Companies ASPI Alternatives LXFR Alternatives ARQ Alternatives SLI Alternatives SDST Alternatives ORGN Alternatives AMTX Alternatives VGAS Alternatives ALTO Alternatives TLGY Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CBUS) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cibus, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cibus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
